by McKesson Ventures | Sep 19, 2023 | Press Releases
Clinical Ink, a leading provider of decentralized clinical trial technology and data services, has recently announced significant enhancements to its data management services. These improvements are accompanied by the addition of new senior hires who will further...
by McKesson Ventures | Jun 20, 2023 | Press Releases
Clinical Ink, a global life science technology company, has announced the appointment of Andrew Kraus as chief technology officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials. Kraus is an...
by McKesson Ventures | Jun 12, 2023 | Portfolio News
Clinical Ink Senior Director Enterprise Architecture Alex Doan recently wrote a case study about how the company chose to use the Rockset analytics platform to improve query speed and other performance metrics. He began by explaining Clinical Ink, which he described...
by McKesson Ventures | May 25, 2023 | Portfolio News
Results from the 12-month, multicenter, observational study, WATCH-PD, were recently published in the journal Nature. The researchers found significant associations between digital biomarkers with a wearable device and conventional clinical scoring methods used in...
by McKesson Ventures | Apr 25, 2023 | Press Releases
Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available...
